StockDriftsStockDriftsTop 2 Trv Gp IV LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| MAZE | MAZE THERAPEUTICS, INC. | 52.63% | 4.47M | $133.5M | +0.00%(+0) | $11.01(+143.82%) | 2026-06-30 | |
| TNGX | TANGO THERAPEUTICS, INC. | 47.37% | 6.37M | $120.2M | +0.00%(+0) | $12.16(+120.49%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +24.64% | +93.63% | -10.29% | -41.91% |
| Top 20 Holdings Unweighted | +47.83% | +223.03% | +17.85% | +127.35% |
Trv Gp IV LLC reports $253.68M in US-listed equity holdings across 2 positions in its most recent 13F filing. Its largest disclosed positions are MAZE (52.6%) and TNGX (47.4%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +93.63% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Sign up free to track Trv Gp IV LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Trv Gp IV LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1688325). View Trv Gp IV LLC’s 13F filings on SEC